Literature DB >> 7649539

Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA.

P M Matthews1, R M Brown, K Morten, D Marchington, J Poulton, G Brown.   

Abstract

Studies in vitro have shown that a respiratory-deficient phenotype is expressed by cells when the proportion of mtDNA with a disease-associated mutation exceeds a threshold level, but analysis of tissues from patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) have failed to show a consistent relationship between the degree of heteroplasmy and biochemical expression of the defect. One possible explanation for this phenomenon is that there is variation of heteroplasmy between individual cells that is not adequately reflected by the mean heteroplasmy for a tissue. We have confirmed this by study of fibroblast clones from subjects heteroplasmic for the MELAS 3243 (A-->G) mtDNA mutation. Similar observations were made with fibroblast clones derived from two subjects heteroplasmic for the 11778 (G-->A) mtDNA mutation of Leber's hereditary optic neuropathy. For the MELAS 3243 mutation, the distribution of mutant mtDNA between different cells was not randomly distributed about the mean, suggesting that selection against cells with high proportions of mutant mtDNA had occurred. To explore the way in which heteroplasmic mtDNA segregates in mitosis we followed the distribution of heteroplasmy between clones over approximately 15 generations. There was either no change or a decrease in the variance of intercellular heteroplasmy for the MELAS 3243 mutation, which is most consistent with segregation of heteroplasmic units of multiple mtDNA molecules in mitosis. After mitochondria from one of the MELAS 3243 fibroblast cultures were transferred to a mitochondrial DNA-free (rho0) cell line derived from osteosarcoma cells by cytoplast fusion, the mean level and intercellular distribution of heteroplasmy was unchanged. We interpret this as evidence that somatic segregation (rather than nuclear background or cell differentiation state) is the primary determinant of the level of heteroplasmy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649539     DOI: 10.1007/bf00210404

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

Review 1.  Diseases of the mitochondrial DNA.

Authors:  D C Wallace
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome [tRNA(Leu(UUR))].

Authors:  B Obermaier-Kusser; I Paetzke-Brunner; C Enter; J Müller-Höcker; S Zierz; W Ruitenbeek; K D Gerbitz
Journal:  FEBS Lett       Date:  1991-07-29       Impact factor: 4.124

3.  Leber's hereditary optic neuropathy as a cause of severe visual loss in childhood.

Authors:  C M Moorman; J S Elston; P Matthews
Journal:  Pediatrics       Date:  1993-05       Impact factor: 7.124

4.  Noninvasive diagnosis of the MELAS syndrome from blood DNA.

Authors:  J Poulton; K Morten
Journal:  Ann Neurol       Date:  1993-07       Impact factor: 10.422

5.  Assignment of two mitochondrially synthesized polypeptides to human mitochondrial DNA and their use in the study of intracellular mitochondrial interaction.

Authors:  N A Oliver; D C Wallace
Journal:  Mol Cell Biol       Date:  1982-01       Impact factor: 4.272

6.  Mitochondrial DNA mutations associated with neuromuscular diseases: analysis and diagnosis using the polymerase chain reaction.

Authors:  D C Wallace; M T Lott; A M Lezza; P Seibel; A S Voljavec; J M Shoffner
Journal:  Pediatr Res       Date:  1990-11       Impact factor: 3.756

7.  Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF).

Authors:  L Boulet; G Karpati; E A Shoubridge
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

8.  Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  M P King; Y Koga; M Davidson; E A Schon
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

9.  Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy.

Authors:  S R Hammans; M G Sweeney; I J Holt; J M Cooper; A Toscano; J B Clark; J A Morgan-Hughes; A E Harding
Journal:  J Neurol Sci       Date:  1992-01       Impact factor: 3.181

10.  Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles.

Authors:  M Yoneda; T Miyatake; G Attardi
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

View more
  11 in total

1.  Identification of the minor component of a mixed stain by using mismatch primer-induced restriction sites in amplified mtDNA.

Authors:  R Szibor; M Michael; I Plate; H Wittig; D Krause
Journal:  Int J Legal Med       Date:  2003-04-09       Impact factor: 2.686

Review 2.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

3.  Single-cell analysis of mitochondrial DNA in patients and a carrier of the tRNA(Leu)(UUR) gene mutation.

Authors:  S Saitoh; M Y Momoi; T Yamagata; H Nakauchi; K Nihei; M Fujii
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

4.  Longitudinal study of a heteroplasmic 3460 Leber hereditary optic neuropathy family by multiplexed primer-extension analysis and nucleotide sequencing.

Authors:  S S Ghosh; E Fahy; I Bodis-Wollner; J Sherman; N Howell
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

5.  Synthesis of mitochondrial DNA in permeabilised human cultured cells.

Authors:  C F Emmerson; G K Brown; J Poulton
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

Review 6.  Applications of magnetic resonance spectroscopy to diagnosis and monitoring of mitochondrial disease.

Authors:  P M Matthews; T Taivassalo
Journal:  Ital J Neurol Sci       Date:  1997-12

7.  Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A-->G mutation in blood.

Authors:  Harsha Karur Rajasimha; Patrick F Chinnery; David C Samuels
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

8.  Systematic segregation to mutant mitochondrial DNA and accompanying loss of mitochondrial DNA in human NT2 teratocarcinoma Cybrids.

Authors:  Carrie J Turner; Caroline Granycome; Rachel Hurst; Elizabeth Pohler; M Katariina Juhola; Martti I Juhola; Howard T Jacobs; Lesley Sutherland; Ian J Holt
Journal:  Genetics       Date:  2005-06-08       Impact factor: 4.562

9.  Genotypic stability, segregation and selection in heteroplasmic human cell lines containing np 3243 mutant mtDNA.

Authors:  S K Lehtinen; N Hance; A El Meziane; M K Juhola; K M Juhola; R Karhu; J N Spelbrink; I J Holt; H T Jacobs
Journal:  Genetics       Date:  2000-01       Impact factor: 4.562

10.  Preventing the transmission of pathogenic mitochondrial DNA mutations: Can we achieve long-term benefits from germ-line gene transfer?

Authors:  David C Samuels; Passorn Wonnapinij; Patrick F Chinnery
Journal:  Hum Reprod       Date:  2013-01-07       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.